There are 702 resources available
Q&A, summary, and meeting closure
Presenter: Ian Chau
Session: Bristol Myers Squibb - Evolving clinical landscape in GI cancer: Immuno-oncology and novel therapies
Resources:
Webcast
Panel discussion
Presenter: Thomas Seufferlein
Session: Servier - Pathways to enhance patients' benefits in metastatic pancreatic cancer
Resources:
Webcast
Conclusion
Presenter: Thomas Seufferlein
Session: Servier - Pathways to enhance patients' benefits in metastatic pancreatic cancer
Resources:
Webcast
Exploring new opportunities to improve outcomes in patients with HER2+ mCRC
Presenter: Zev Wainberg
Session: Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers
Resources:
Webcast
The Evolution of HER2 positivity in the treatment of biliary tract cancers
Presenter: Zev Wainberg
Session: Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers
Resources:
Webcast
Safety considerations of HER2-directed therapy in GI cancers
Presenter: Sara Lonardi
Session: Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers
Resources:
Webcast
Our message worth sharing
Presenter: Josep Tabernero
Session: Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers
Resources:
Webcast
Treatment of MSI-high metastatic colon cancer
Presenter: Gerald Prager
Session: Metastatic colon cancer
Resources:
Slides
Webcast
New targets and new drugs
Presenter: Santiago Ponce Aix
Session: New targets in immunotherapy beyond CTL4 and PD(L)1
Resources:
Slides
Webcast
Treatment of MSS colon cancer first- line, maintenance: Current and future options, future
Presenter: Chiara Cremolini
Session: Metastatic colon cancer
Resources:
Slides
Webcast